Viewing Study NCT07301450


Ignite Creation Date: 2025-12-24 @ 5:12 PM
Ignite Modification Date: 2025-12-26 @ 1:58 AM
Study NCT ID: NCT07301450
Status: TEMPORARILY_NOT_AVAILABLE
Last Update Posted: 2025-12-24
First Post: 2025-02-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Expanded Access Program of Garetosmab in Adult Patients With Fibrodysplasia Ossificans Progressiva (FOP)
Sponsor: Regeneron Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module